Our Patent Litigation team is a proud partner to the world鈥檚 most innovative life sciences and technology companies. Our experience successfully handling high-stakes patent matters, joined with Paul, Weiss's legendary litigation capabilities, enable us to provide comprehensive strategies to protect our clients鈥� most valuable innovations that extend well beyond traditional patent litigation.
Outside Counsel: 'MedImmune v. Genentech': Unanswered Questions
February 1, 2007 Full PDF
Litigation partner Catherine Nyarady published an article, "'MedImmune v. Genentech': Unanswered Questions," in the February 1 New York Law Journal. The article discusses the Supreme Court's ruling, which held that a patent licensee has jurisdiction to seek a declaratory judgement of noninfringement, patent invalidity or unenforceability against the licensor-patentee, even if the licensee continues to pay royalties under the license agreement. This decision reversed the previous ruling by the U.S. Court of Appeals for the Federal Circuit. The article also reflects on some important issues the Supreme Court left unanswered in the case. Associate Benjamin Warlick assisted with the preparation of this article.